- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03919747
Oral Contraceptives in Reproductive Age Women
April 17, 2019 updated by: Mine Kiseli, Ufuk University
The Awareness About Oral Contraceptives in Reproductive Age Women
Contraception is an important issue in public health; especially when maternal risks and morbidities are considered.
There is a need for consciousness about the contraceptive choices.
The reproductive age women in Turkey may be stubborn or may choose to believe heath information.
The oral contraceptive drugs are not used because of wrong beliefs.
This survey study aims to investigate the consciousness and knowledge about the oral contraceptives in 3 different areas in Turkey.
Study Overview
Status
Unknown
Conditions
Detailed Description
In this study; surveys will be given to reproductive age women admitting to the obstetrics and gynecology departments in 3 different cities of Turkey.
Survey questions start with the education and socioeconomical status of the participants.
Mainly the questions include the knowledge, ever use about oral contraceptives.
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Karabük, Turkey
- Recruiting
- Karabuk University Hospital
-
Contact:
- Sibel Mutlu
-
Kayseri, Turkey
- Recruiting
- Acıbadem Private Hospital
-
Contact:
- Elif Cinar
-
-
Çankaya
-
Ankara, Çankaya, Turkey, 06540
- Recruiting
- Ufuk University Dr Ridvan Ege Hospital
-
Contact:
- Mine Kiseli
- Phone Number: 5325080110
- Email: minekiseli@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Reproductive aged women
Description
Inclusion Criteria: The women admitting to the clinics -
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge about oral contraceptives
Time Frame: 6 months of survey study
|
The number of participants who had knowledge about the correct use of OC pills
|
6 months of survey study
|
|
Contraindications of OC pills
Time Frame: 6 months of survey study
|
The number of participants who know the contraindications of OC pills /The number of participants who think that OC pills cause infertility
|
6 months of survey study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge difference in between different regions
Time Frame: 6 months of survey study
|
The number of participants who had knowledge about the correct use of OC pills in different regions
|
6 months of survey study
|
|
Oral contraceptive use
Time Frame: 6 months of survey study
|
The number of participants that have ever used oral contraceptive pills
|
6 months of survey study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Recai Pabuccu, Prof., The Turkish Reproductive Medicine Association
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 2, 2019
Primary Completion (ANTICIPATED)
June 2, 2019
Study Completion (ANTICIPATED)
July 30, 2019
Study Registration Dates
First Submitted
March 16, 2019
First Submitted That Met QC Criteria
April 17, 2019
First Posted (ACTUAL)
April 18, 2019
Study Record Updates
Last Update Posted (ACTUAL)
April 18, 2019
Last Update Submitted That Met QC Criteria
April 17, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 20180528/4
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.